Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 May;66(2):91-8.
doi: 10.1016/j.critrevonc.2007.09.003. Epub 2007 Oct 31.

Role of insulin-like growth factor-1R system in colorectal carcinogenesis

Affiliations
Review

Role of insulin-like growth factor-1R system in colorectal carcinogenesis

Erin A Donovan et al. Crit Rev Oncol Hematol. 2008 May.

Abstract

The insulin-like growth factor (IGF) system is comprised of receptors, ligands (IGF-I and IGF-II), and a family of binding proteins (IGFBPs). It plays an important role in growth and development and in the maintenance of normal homeostasis. We present a review of the current laboratory and epidemiologic evidence that suggests an important role of the IGF system in colorectal carcinogenesis. Due to the complexity of this system, we have focused the review on the role of the IGF-1 receptor and its ligands in colorectal carcinogenesis and the strategies to block this pathway as a potential anti-cancer therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Insulin-like growth factor I receptor (IGF-1R): IGF-1R is a tyrosine kinase cell-surface receptor containing two α and two β subunits joined by disulfide bridges forming a heterotetrameric receptor complex. When ligand binds to IGF-1R, a conformational change occurs, leading to trans-autophosphorylation of the cytoplasmic tyrosine kinase domain, resulting in activation of the PI3K and Raf/MAPK pathways. [PI3K, phosphatidylinositol 3-kinase; TOR, target of rapamycin; MEK, mitogen-activated protein kinase kinase; ERK, extracellular signal-regulated kinase; Raf/MAPK, RAF-mitogen-activated protein kinase]

References

    1. Yakar S, Leroith D, Brodt P. The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models. Cytokine Growth Factor Rev. 2005;16:407–420. - PubMed
    1. Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer. 2004;4:505–518. - PubMed
    1. Durai R, Yang W, Gupta S, et al. The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge. Int J Colorectal Dis. 2005;20:203–220. - PubMed
    1. Jehle PM, Fussgaenger RD, Blum WF, et al. Differential autocrine regulation of intestine epithelial cell proliferation and differentiation by insulin-like growth factor (IGF) system components. Horm Metab Res. 1999;31:97–102. - PubMed
    1. Wu Y, Yakar S, Zhao L, et al. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res. 2002;62:1030–1035. - PubMed

Publication types

MeSH terms